Ranolazin Accord 375 mg tablete s produljenim oslobađanjem
Name | Ranolazin Accord 375 mg tablete s produljenim oslobađanjem |
---|---|
Marketing Authorisation Number | HR-H-188739599 |
Active Substance | ranolazin |
Composition | jedna tableta sadrži 375 mg ranolazina |
Pharmaceutical Form | Tableta s produljenim oslobađanjem |
Manufacturer | Accord Healthcare B.V., Utrecht, Nizozemska
Accord Healthcare Polska Sp. z o.o., Pabianice, Poljska Pharmadox Healthcare Limited, Paola, Malta |
Marketing Authorisation Holder | Accord Healthcare Polska Sp. z o.o., Ul. Tasmowa 7, Mazowieckie, Varšava, Poljska |
Marketing Authorisation Date | 17.05.2024 |
MA Period of Validity | 17.05.2029 |
Classification Number | UP/I-530-09/21-01/293 |
Registration Number | 381-12-01/70-24-09 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | C01EB18 |
SmPC | download |
PL | download |
Public Assessment Report | download |